Literature DB >> 10975812

The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells.

Z Dai1, B T Konieczny, F G Lakkis.   

Abstract

The mechanisms responsible for the generation and maintenance of T cell memory are unclear. In this study, we tested the role of IL-2 in allospecific CD8+ T cell memory by analyzing the long-term survival, phenotype, and functional characteristics of IL-2-replete (IL-2+/+) and IL-2-deficient (IL-2-/-) CD8+ TCR-transgenic lymphocytes in an adoptive transfer model. We found that IL-2 is not essential for the in vivo generation, maintenance, or recall response of CD8+ memory T cells. However, IL-2 increased the size of the CD8+ memory pool if present at the time of initial T cell activation but reduced the size of the pool if present during memory maintenance by inhibiting the proliferation of CD8+ memory T cells. Thus, IL-2-based vaccine strategies or immunosuppressive regimens that target IL-2 should take into account the divergent roles of IL-2 in CD8+ T cell immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975812     DOI: 10.4049/jimmunol.165.6.3031

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs.

Authors:  Geetha Chalasani; Zhenhua Dai; Bogumila T Konieczny; Fady K Baddoura; Fadi G Lakkis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 2.  Routes to transplant tolerance versus rejection; the role of cytokines.

Authors:  Patrick T Walsh; Terry B Strom; Laurence A Turka
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

Review 3.  Inflammation and transplantation tolerance.

Authors:  Daniel R Goldstein
Journal:  Semin Immunopathol       Date:  2011-02-18       Impact factor: 9.623

4.  Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice.

Authors:  Philip J Lucas; Seong-Jin Kim; Crystal L Mackall; William G Telford; Yu-Waye Chu; Frances T Hakim; Ronald E Gress
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

5.  Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.

Authors:  Haofeng Ji; Xiu-Da Shen; Feng Gao; Ronald W Busuttil; Yuan Zhai; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2011-05-27       Impact factor: 4.939

6.  Influenza virus-specific immunological memory is enhanced by repeated social defeat.

Authors:  Jacqueline W Mays; Michael T Bailey; John T Hunzeker; Nicole D Powell; Tracey Papenfuss; Erik A Karlsson; David A Padgett; John F Sheridan
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

7.  Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.

Authors:  Kyle K Payne; Christine K Zoon; Wen Wan; Khin Marlar; Rebecca C Keim; Mehrab Nasiri Kenari; A Latif Kazim; Harry D Bear; Masoud H Manjili
Journal:  Breast Cancer Res Treat       Date:  2013-10-25       Impact factor: 4.872

Review 8.  Interleukin 2: from immunostimulation to immunoregulation and back again.

Authors:  Martin F Bachmann; Annette Oxenius
Journal:  EMBO Rep       Date:  2007-12       Impact factor: 8.807

9.  DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory.

Authors:  Teresa Lambe; Greg Crawford; Andy L Johnson; Tanya L Crockford; Tiphaine Bouriez-Jones; Aisling M Smyth; Trung H M Pham; Qian Zhang; Alexandra F Freeman; Jason G Cyster; Helen C Su; Richard J Cornall
Journal:  Eur J Immunol       Date:  2011-11-10       Impact factor: 5.532

10.  Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells.

Authors:  Shuzi Zhang; Hehua Dai; Ni Wan; Yolonda Moore; Zhenhua Dai
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.